KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Finished Goods (2020 - 2023)

Ginkgo Bioworks Holdings filings provide 4 years of Finished Goods readings, the most recent being $4.4 million for Q2 2023.

  • On a quarterly basis, Finished Goods fell 41.06% to $4.4 million in Q2 2023 year-over-year; TTM through Jun 2023 was $4.4 million, a 41.06% decrease, with the full-year FY2022 number at $6.6 million, up 100.86% from a year prior.
  • Finished Goods hit $4.4 million in Q2 2023 for Ginkgo Bioworks Holdings, down from $5.3 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $8.0 million in Q1 2022 to a low of $2.5 million in Q3 2021.
  • Median Finished Goods over the past 4 years was $5.3 million (2023), compared with a mean of $5.1 million.
  • Biggest five-year swings in Finished Goods: surged 120.66% in 2022 and later tumbled 41.06% in 2023.
  • Ginkgo Bioworks Holdings' Finished Goods stood at $2.8 million in 2020, then rose by 18.43% to $3.3 million in 2021, then surged by 100.86% to $6.6 million in 2022, then tumbled by 32.35% to $4.4 million in 2023.
  • The last three reported values for Finished Goods were $4.4 million (Q2 2023), $5.3 million (Q1 2023), and $6.6 million (Q4 2022) per Business Quant data.